<b style="">Pharmaceutical development of novel microalgal compounds for Mdr <i style="">Mycobacterium</i> <i style="">tuberculosis</i></b>
IR@NISCAIR: CSIR-NISCAIR, New Delhi - ONLINE PERIODICALS REPOSITORY (NOPR)
View Archive Info| Field | Value | |
| Creator |
Prakash, S
Bhimba, B Valentin |
|
| Date |
2010-04-19T04:35:27Z
2010-04-19T04:35:27Z 2005-08 |
|
| Identifier |
0975-1092 (Online); 0972-592X (Print)
http://hdl.handle.net/123456789/8104 |
|
| Description |
264-269
The role of marine algae in the discovery of drugs that could reach the pharmaceutical market has increased notably in recent years, due to a substantial improvement in biological screening methods. Multi Drug Resistant (MDR) TB is the major hurdle in the TB control programmes. The selected resistant strains of Mycobacterium tuberculosis were screened for the bioactive compounds extracted from marine microalgae. It is noted that Isochrysis galbana has rich bioactive compounds than the other algal species. |
|
| Language |
en_US
|
|
| Publisher |
CSIR
|
|
| Relation |
<b>Int. cl.<sup>7</sup> — </b>A61K 35/80, A61P 31/06
|
|
| Source |
NPR Vol.4(4) [July-August 2005]
|
|
| Subject |
Marine microalgae
Microalgal compounds Tuberculosis Mdr TB <i style="">Mycobacterium</i> <i style="">tuberculosis</i> <i>Isochrysis galbana</i> |
|
| Title |
<b style="">Pharmaceutical development of novel microalgal compounds for Mdr <i style="">Mycobacterium</i> <i style="">tuberculosis</i></b>
|
|
| Type |
Article
|
|